Ali Khademhosseini, PhD, is the Levi Knight Professor of Bioengineering, Chemical Engineering, and Radiology at the Univ. of California, Los Angeles (UCLA) (Phone: (310) 206-5819; Fax: (310) 794-5956; Email: khademh@ucla.edu). He is the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA, as well as an associate director of the California NanoSystems Institute. He joined UCLA in Nov. 2017 after working as a professor of medicine at Harvard Medical School. He is recognized as a leader in combining micro- and nanoengineering approaches with advanced biomaterials for regenerative medicine applications. He has authored over 500 journal papers and 60 books/chapters. Khademhosseini has won over 40 major national and international awards, including the Presidential Early Career Award for Scientists and Engineers (2011), the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (2011) for his contribution to microscale tissue engineering and microfluidics, the Senior Scientist Award of the Tissue Engineering and Regenerative Medicine Society — Americas Chapter (2016), and the Clemson Award of the Society for Biomaterials (2017). He is also a fellow of societies including the Materials Research Society, Biomedical Engineering Society, Royal Society of Chemistry, Society for Biomaterials, and American Association for the Advancement of Science. He serves on the editorial board of numerous leading journals and is an associate editor for ACS Nano. Khademhosseini received his PhD in bioengineering from MIT and MASc and BASc degrees from the Univ. of Toronto, both in chemical engineering.